A Study on the Impact of Monitoring Rehabilitation Progress on the Continuation of Home-based Rehabilitation

UMIN ID: UMIN000055700

Registered date:02/10/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Orthopedic Disorders (Postoperative or Under Conservative Therapy)
• Date of first enrollment: 2024/10/21
• Target sample size: 30
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

In the intervention group, patients will self-record the number of home-based rehabilitation sessions on a provided log sheet. Once a week, during outpatient visits, the research staff will review the log and use Excel to create a cumulative bar graph representing the total number of sessions. This graph will be printed on an A4 sheet and given to the patient to provide visual feedback on their rehabilitation progress. The intervention period is 3 months, with follow-up occurring once a week.
In the control group, patients will self-record the number of home-based rehabilitation sessions on a provided log sheet, but progress visualization (creating and providing graphs) will not be conducted. The intervention period is 3 months, and during weekly outpatient visits, the research staff will review the rehabilitation records without providing any graphical feedback.

Outcome(s)

• Primary Outcome: Whether or not home-based self-rehabilitation was continued (Assessment timing: 3 months after the start of the trial)
• Secondary Outcome: Changes in joint range of motion and muscle strength (Assessment timing: at the start of the trial and 3 months after)

Key inclusion & exclusion criteria

• Age minimum: 50years-old
• Age maximum: 70years-old
• Gender: Male and Female
• Exclude criteria: 1.Patients with Alzheimers disease, dementia, or other cognitive impairments requiring treatment 2.Patients with severe mental disorders requiring treatment, such as major depression or schizophrenia 3.Patients with severe comorbidities such as heart failure NYHA class III or IV, renal failure eGFR less than 30 mL per min per 1.73 square meters, or respiratory diseases predicted value less than 50 percent in lung function tests 4.Patients with systemic diseases such as rheumatoid arthritis that restrict movement 5.Patients with infections or other complications at the surgical site 6.Patients participating in other research studies that may interfere with this studys rehabilitation intervention 7.Any other patients deemed unsuitable by the study investigator

Related Information

• Primary Sponsor: Kobe University
• Source(s) of Monetary Support: Kobe University